InVivo Therapeutics

InVivo Therapeutics Corporation has added George Nolen, former President and CEO of Siemens Corporation, to its Board of Directors. The Board approved the appointment on Friday, December 11th 2009.
Read More

InVivo Therapeutics Corporation has filed an Investigational Device Exemption application with the Food and Drug Administration requesting permission to advance to human clinical studies. InVivo is currently conducting its third primate study and expects to receive approval to begin a human study in 2010.
Read More

InVivo Therapeutics and CEO Frank Reynolds are featured in this article under the section titled "Fulfilling a life's mission".
Read More

Frank Reynolds, InVivo Therapeutics President and CEO, has been identified as one of ‘‘America’s most innovative entrepreneurs’ in the October 2009 issue of Inc. Magazine. In the article entitled “The New and Improved You,” Inc. highlights ten medical technologies being developed to treat different parts of the body, including a section on “The Spine” featuring Reynolds and InVivo Therapeutics.
Read @ Inc.com

InVivo Therapeutics Corporation hosted Ilya Ponomarev, a member of the Russian Parliament, on Thursday September 3, 2009 as part of his national tour of important emerging technologies. Ponomarev, who is Chairman of the State Duma’s Hi-Tech Development Subcommittee, visited InVivo Therapeutics at their headquarters in Kendall Square. While there, Ponomarev had the opportunity to speak with and listen to a presentation by InVivo President and CEO Frank Reynolds.
Read More

Frank Reynolds InVivo Therapeutics’ President and CEO has been invited to join the review panel at the Massachusetts Stem Cell Bank, located in Shrewsbury at the University of Massachusetts Medical School campus. Reynolds will become a permanent member of the panel and will be charged with helping to determine strategic direction and initiatives for the Bank, which was launched in 2008.
Read More

We aren't just using [our interns] for idle time work, they are involved in tasks crucial to this company," Reynolds said. He added that the interns participate in all the company's internal meetings, allowing them to see the inner workings of business and the logic behind the company's decisions."
Read More

Massachusetts Governor Deval Patrick recognizes InVivo as a model for life science companies in Massachusetts.
Watch Video

InVivo Therapeutics President and CEO Frank Reynolds will introduce Massachusetts Governor Deval Patrick for his keynote speech at Bio2009. Bio2009 is a four-day annual convention for biotechonology being held in Atlanta from May 18-21, 2009.
Read More  Watch Video

Robert Johnson, Special Olympics Massachusetts President and CEO, is enthusiastic about the addition of Reynolds. He is looking forward to the potential and drive that Reynolds will bring to Special Olympics Massachusetts, a drive that helped Reynolds to found InVivo Therapeutics and develop it into a company that is bringing hope to those who suffer traumatic spinal cord injuries. "We are delighted to add Frank to our growing list of talented and influential individuals who work throughout the year to provide our athletes with the best sports training and competition program possible," says Johnson. "His passion for improving the quality of the lives of people with disabilities, combined with his extraordinary talents in the field of business, makes him the perfect candidate for our board."
Read More

The Accelerator Program, designed to provide support to early-stage life sciences companies that demonstrate a strong potential for commercialization and growth, is one facet of the state's $1 billion Massachusetts Life Sciences Act. InVivo Therapeutics was selected as an award recipient after a competitive application process that included both peer review and a presentation before the MLSC Scientific Advisory Board. According to MLSC President and CEO Dr. Susan Windham-Bannister: "We have great confidence in your outstanding team and technology, and in your ability to benefit humanity while creating jobs for the commonwealth of Massachusetts."
Read More

InVivo Therapeutics CEO Frank Reynolds appears on NECN Business Day with MLSC CEO Susan Windham-Bannister to discuss the Accelerator Program Grant and InVivo’s novel technology.
Watch Video

InVivo Therapeutics President and CEO Frank Reynolds has received several nominations for the Massachusetts Technology Leadership Council 'CEO of the Year' award. As a nominee for a 2009 Mass Technology Leadership Award, Reynolds is being recognized as one of the strongest leaders in the Massachusetts technology community.
Read More

ICCUSA member Mr. Frank Reynolds, CEO of InVivo Therapeutics of Cambridge, MA gave an incredible presentation highlighting cutting edge R&D the company is engaged in for the treatment of acute and chronic spinal cord injuries. InVivo’s medical breakthroughs may very well prove life changing for many individuals with limited mobility due to spinal cord related injuries.
Read More

He knew immediately he wanted to work for InVivo. "At first I thought I could work on the business end, but then it dawned on me the important role chemical engineering plays in tissue remodeling and drug delivery," said Pritchard.
Read More

InVivo CEO Frank Reynolds received an enthusiastic response after giving a company presentation to Governor Patrick and Dr. Windham-Bannister. The group had the chance to ask questions and speak about the potential that InVivo's technology holds. Said Governor Patrick "This is amazing work you’re doing. We look forward to you bringing this technology to market, and to the 600+ jobs you can bring to Massachusetts."
Read More